Back to Trades
O'Neill Gilmore Neil
CEODirectorCIK 0001742084
Total Volume
$134.8K
6 filings
Purchases
$0
0 buy txns
Sales
$134.8K
5 sell txns
Net Activity
-$134.8K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
O'Neill Gilmore Neil, CEO, Director, has filed 6 SEC reports (2025–2026), all concentrated in Editas Medicine, Inc. (EDIT), totaling $134.8K in disclosed volume. Weighing $0 bought versus $134.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Nov 13 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $51.1K |
| Nov 6 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Grant | $0 |
| Sep 4 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $15.6K |
| Jun 5 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $41.5K |
| Dec 4 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $12.1K |
| Sep 4 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $14.5K |
6 filings